Haleon (LSE: HLN, NYSE: HLN) is a publicly listed company headquartered in Weybridge, United Kingdom that owns 8 consumer brands across 3 categories, and has 1 recorded transaction.[1]
Haleon is the consumer health business demerged from GSK in July 2022, having earlier absorbed Pfizer's consumer health portfolio through a joint venture. It is the largest standalone consumer health company in the world, built on oral health, pain relief, respiratory health and vitamins.
brands owned
3
categories
1
acquisitions recorded · 1 since 2015
0
divestitures recorded
Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.
Full-screen interactive tree → · Download as infographic
GSK demerged its consumer healthcare business as Haleon, listing it in London and New York in July 2022. The business already contained Pfizer's consumer health portfolio, contributed to a joint venture in 2019, which is how Advil and Centrum came to sit alongside Sensodyne and Panadol.
No tagged news items yet. Headlines are added nightly from public feeds; only titles and links are stored.
Headlines link to the original publisher. Brandtree does not reproduce article text.
Haleon owns 8 consumer brands tracked here, including Parodontax, Polident, Panadol, Voltaren, Advil and Sensodyne.
Yes. Haleon is headquartered in Weybridge, United Kingdom and was founded in 2022.
Haleon is a publicly listed company owned by its shareholders; it trades as HLN on the LSE and HLN on the NYSE.
The most recent completed acquisition recorded here is Sensodyne, Panadol, Voltaren, Centrum, Advil, Polident, Otrivin and Parodontax on 18 July 2022.
Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.
Report a correction Opens a pre-filled GitHub issue. See our corrections policy.